Drug Type Chemical drugs |
Synonyms Tumor necrosis factor alpha (TNFα)-binding imprinted polymers |
Target |
Action inhibitors |
Mechanism TNF-α inhibitors(Tumor necrosis factor α inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colitis, Ulcerative | Preclinical | Hungary | 01 Aug 2023 | |
| Colitis, Ulcerative | Preclinical | Israel | 01 Aug 2023 | |
| Crohn Disease | Preclinical | Hungary | 01 Aug 2023 | |
| Crohn Disease | Preclinical | Israel | 01 Aug 2023 |





